Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Depreciation & Amortization (CF): 2019-2024

Historic Depreciation & Amortization (CF) for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to $10.6 million.

  • Cellebrite DI's Depreciation & Amortization (CF) rose 3.09% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 1.54%. This contributed to the annual value of $10.6 million for FY2024, which is 5.95% up from last year.
  • As of FY2024, Cellebrite DI's Depreciation & Amortization (CF) stood at $10.6 million, which was up 5.95% from $10.0 million recorded in FY2023.
  • Over the past 5 years, Cellebrite DI's Depreciation & Amortization (CF) peaked at $10.6 million during FY2024, and registered a low of $5.9 million during FY2020.
  • Its 3-year average for Depreciation & Amortization (CF) is $9.9 million, with a median of $10.0 million in 2023.
  • Data for Cellebrite DI's Depreciation & Amortization (CF) shows a peak YoY surged of 44.13% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Cellebrite DI's Depreciation & Amortization (CF) stood at $5.9 million in 2020, then rose by 19.19% to $7.0 million in 2021, then soared by 31.21% to $9.2 million in 2022, then grew by 8.89% to $10.0 million in 2023, then increased by 5.95% to $10.6 million in 2024.